Malignant Hypercalcaemia — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Start monitored hydration, calcitonin and renal-adjusted antiresorptive treatment at presentation
Explanation lettering: B = shown as A · E = shown as B · D = shown as C · A = shown as D · C = shown as E
B is correct because severe symptomatic hypercalcaemia requires volume restoration, a rapid bridge such as calcitonin and definitive antiresorptive therapy chosen with kidney function in mind. C omits initial volume treatment and delays therapy for a result that does not change the emergency threshold. D reduces urinary calcium excretion. E ignores rapid calcitonin tachyphylaxis and the need for durable control. A is insufficient definitive therapy and may overload a patient with renal impairment. Electrolytes, ECG, fluid balance and cancer-directed treatment are reviewed concurrently.
Reference: eviQ, Hypercalcaemia of malignancy: https://www.eviq.org.au/clinical-resources/oncological-emergencies/486-hypercalcaemia-of-malignancy-hcm